Prostate Cancer

Understanding Prostate Screening & Treatment Options

For some types of cancer, screening can help find cancers at an early stage, when they are more likely to be easier to treat. According to the American Cancer Society, prostate cancer can often be found before symptoms arise by testing the amount of prostate-specific antigen (PSA) in a man’s blood. Another way to find prostate cancer is the digital rectal exam (DRE), in which the doctor puts a gloved, lubricated finger into the rectum to feel the prostate gland. If the results of either one of these tests are abnormal, further testing is often done to see if a man has cancer. If prostate cancer is found as a result of screening with the PSA test or DRE, it will probably be at [...]

2019-12-03T10:47:39-08:00December 3rd, 2019|

A Typical HIFU Procedure Day

Wake up, get ready, and head to the treatment facility. Patients will need to complete their bowel prep per their MD’s instruction. This is comparable to a prostate biopsy bowel prep. 6 am – 7 am | Arrive at treatment facility, be greeted by staff, and enter procedure preparation area. Patients will typically be asked to arrive at the treatment facility at least an hour before the procedure. 7 am – 10 am | Sonablate HIFU Procedure A typical HIFU procedure lasts between 2-4 hours (depending on the size of the prostate) and is either done under general anesthesia or an epidural and IV sedation. During the procedure a catheter will be put in place to help with urination, and will stay in [...]

2019-11-19T09:50:33-08:00November 12th, 2019|

Researchers identify new factors that may help reduce prostate cancer risk

Men with higher levels of 'free' testosterone and a growth hormone in their blood are more likely to be diagnosed with prostate cancer, according to research presented at the 2019 NCRI Cancer Conference. Other factors such as older age, ethnicity and a family history of the disease are already known to increase a man's risk of developing prostate cancer. However, the new study of more than 200,000 men is one of the first to show strong evidence of two factors that could possibly be modified to reduce prostate cancer risk. The research was led by Dr Ruth Travis, an Associate Professor, and Ellie Watts, a Research Fellow, both based at the Nuffield Department of Population Health, University of Oxford, UK. Dr Travis said: [...]

2019-11-05T08:21:24-08:00November 5th, 2019|

Urine test could offer early detection of prostate cancer

A research study published in the journal Neoplasia and led by principal investigator Nallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene. This unique biomarker can be detected in the urine samples of patients with prostate cancer, offering a non-invasive means of detection. Currently, the prostate specific antigen (PSA) exam is used as the standard screening method for prostate cancer. However, elevated PSA levels are not exclusive to prostate cancer, as they can also be caused by benign prostate conditions. As a result, an elevated PSA test can sometimes lead to an unnecessary prostate biopsy for the patient, which carries [...]

2019-10-08T10:17:47-07:00October 8th, 2019|

Dr. Lazar Selected as Among Sonoma County’s Top Doctors

Santa Rosa urologist and prostate cancer expert Dr. Michael Lazar recognized in the field of Urology as one of the best physicians in Sonoma County. Every year, Sonoma Magazine’s Top Doctor survey polls Sonoma County doctors and medical specialists for physicians they most often recommend to a loved one. This year almost 500 professionals are noted in the September issue as “the crème de la crème” in more than 50 categories. Dr. Lazar was recognized by his medical peers in the field of urology. About Dr. Lazar “I am honored to be among the top doctors recommended by their peers again in this year’s survey,” says Dr. Lazar. “There are so many excellent physicians in Northern California and Sonoma County Magazine helps the highlight [...]

2019-09-10T10:12:37-07:00September 10th, 2019|

Dr. Lazar talks about HIFU for Prostate Cancer Awareness Month

Prostate cancer affects more then 3 million men every year, worldwide. Last year 1 in 9 men in the US were diagnosed with prostate cancer. Genes for disease can run in families. Men who have a relative with prostate cancer are twice as likely to develop the disease, while those with two or more relatives are nearly four times as likely to be diagnosed with prostate cancer themeselves. The risk is even higher when the affected family members were diagnosed before age 65. September is national Prostate Cancer Awareness Month. About 174,650 new cases of this type of cancer are reported each year, along with 31,620 deaths attributed to the disease annually. One in nine men will be diagnosed with prostate cancer during [...]

2019-09-10T09:54:18-07:00September 3rd, 2019|

Random PSA screening misses some aggressive prostate cancers

Researchers point out that inviting men with no symptoms to a one-off PSA test for prostate cancer does not save lives. This from the largest ever prostate cancer trial conducted over 10 years by Cancer Research UK-funded scientists and published in the Journal of the American Medical Association (JAMA). Researchers at the Universities of Bristol and Oxford found that testing asymptomatic men with PSA detects some disease that would be unlikely to cause any harm but also misses some aggressive and lethal prostate cancers. This highlights the flaws of a single PSA test as a way to screen for prostate cancer, and shows the need to find more accurate ways to diagnose cancers that need to be treated. The CAP Trial, which spanned [...]

2019-08-06T07:55:10-07:00August 5th, 2019|

Optimizing prostate cancer treatment options with HIFU

Creating a customized plan optimized for a patient’s specific prostate needs is easier with Sonablate HIFU prostate ablation. “Did you know that prostate cancer can be treated without suffering the side effects of surgery and radiation? I am Dr. Michael Lazar, 4 time board certified urologist, who’s practiced in Santa Rosa for 36 years.  In 2007, I investigated and became an early user of a new technology for treatment of prostate cancer called high intensity focused ultrasound, or HIFU. This exciting non-invasive technology uses ultrasound energy to create heat.  This heat is precisely aimed at the cancerous portions of the gland to kill the cancer while sparing the normal regions.  It is painless, bloodless and causes much less erectile dysfunction and almost no [...]

2019-07-23T09:57:44-07:00July 23rd, 2019|

Researchers Suspect Connection Between Sugar and Prostate Cancer Risks

A study published by The BMJ today reports a possible association between higher consumption of sugary drinks and and an increased risk of cancer. While cautious interpretation is needed, the findings add to a growing body of evidence indicating that limiting sugary drink consumption, together with taxation and marketing restrictions, might contribute to a reduction in cancer cases. The consumption of sugary drinks has increased worldwide during the last few decades and is convincingly associated with the risk of obesity, which in turn is recognized as a strong risk factor for many cancers. But research on sugary drinks and the risk of cancer is still limited. A team of researchers based in France set out to assess the associations between the consumption of [...]

2019-07-15T10:39:13-07:00July 15th, 2019|

Protein identified that promotes aggressive prostate cancer

Study seeks to uncover new strategies to prevent or treat aggressive, late-stage prostate cancerProstate cancer represents a major health challenge and there is currently no effective treatment once it has advanced to the aggressive, metastatic stage. A new has revealed a key cellular mechanism that contributes to aggressive prostate cancer, and supporting a new clinical trial. The study was published in the journal Clinical Cancer Research.The research led by investigators at the Sidney Kimmel Cancer Center -- Jefferson Health (SKCC) and their collaborators at Memorial Sloan Kettering Cancer Center, the University of California, San Francisco, and Celgene Corporation, focused on an enzyme called DNA-PK (DNA-dependent protein kinase), a pivotal component of the cellular machinery that controls both DNA repair and influences gene expression. The [...]

2019-07-03T10:33:46-07:00July 3rd, 2019|